INTRODUCTION
Adult mesenchymal stromal cells (MSCs), defined in vitro by their potential to contribute to bone-cartilage-fat cell lineages, are currently used for cell-based bone and cartilage therapies because of their ready accessibility. However, as for other adult stem cells, it is difficult to obtain sufficient MSCs for treatment. Expansion culture is therefore necessary before transplantation; however, it tends to cause the loss of long-term viability of the MSCs and their capacity to differentiate, especially into chondrocytes (Somoza et al., 2014) . Different types of bone and cartilage are formed most actively during embryonic skeletogenesis from one of three precursor cell types: paraxial mesoderm, lateral plate mesoderm, and cranial neural crest. Such embryonic cells and their osteochondrogenic progeny may be as effective as or more effective than MSCs for the regeneration of adult bone and cartilage.
The early processes of in vitro differentiation of pluripotent embryonic stem cells (ESCs) mimic those of in vivo embryogenesis (Nishikawa et al., 2007) . Therefore, ESCs and induced pluripotent stem cells (iPSCs) (collectively designated pluripotent stem cells or PSCs) would appear to be the practical source of embryonic precursor cells in humans. In fact, in vitro induction of osteogenesis and chondrogenesis from human PSCs (hPSCs) and mouse (mPSCs) has been demonstrated by many groups (Nakayama and Umeda, 2011) . With the exception of recent reports, including ours (Craft et al., 2013; Diekman et al., 2012; Nakayama et al., 2003; Toh et al., 2009; Zhao et al., 2014) , many of the earlier reports described spontaneous differentiation of hPSCs followed by enrichment of mesenchymal cells by further culturing the progeny in MSC medium. As adult human tissue-derived MSCs or chondroprogenitors (Koelling et al., 2009; Pittenger et al., 1999) , mesenchymal cells derived from mESCs/iPSCs were able to be expanded extensively; however, expansion occurred with the loss of their chondrogenic activity (Bakre et al., 2007; Diekman et al., 2012) . Thus far, the potential benefits of bone and cartilage repair of hPSC-derived osteochondroprogenitors over those of adult MSCs, whether in quantity or in quality, have not been demonstrated, even in vitro (Nakayama and Umeda, 2011) . In theory, the wealth of information on the signaling mechanisms involved in mouse skeletogenesis should be of great help in improving the expansion culture methods. However, the unclear embryonic origins of the chondrogenic activity developed from PSCs and the undefined conditions used for expansion have hampered full use of the information and thereby hindered progress.
A large portion of craniofacial bone and cartilage arises from osteochondrogenic progeny (i.e., ectomesenchyme) from cranial neural crest (Santagati and Rijli, 2003) , generated from the junction between anterior neuroectoderm and surface ectoderm (Milet and Monsoro-Burq, 2012) . Neural crest cells have been developed from hESCs in 12-28 days of differentiation culture either through neuroepithelial intermediates induced by suppression of Nodal/ Activin/transforming growth factor b (TGFb) and bone morphogenetic protein (BMP) signaling in a defined medium (Chambers et al., 2009; Smith et al., 2008) or directly by activation of WNT signaling with suppression of Nodal/ Activin/TGFb signaling (Menendez et al., 2011) . Further differentiation and expansion for 2-3 weeks of such neural crest cells or earlier neural cells in a serum-containing medium generate MSC-like cells with variable chondrogenic activity, but never sufficient to reproducibly form cartilage particles that accumulate proteoglycan-rich, mature matrices uniformly (hereafter designated ''full-cartilage'').
Our group has focused on generating and characterizing paraxial mesodermal progeny from mPSCs/hPSCs, which are highly chondrogenic (Tanaka et al., 2009; Zhao et al., 2014 ). In the current study, we report simple, effective methods for the specification of neural crest-like progeny from hPSCs and subsequent generation and expansion of chondrogenically committed ectomesenchymal cells without loss of their chondrogenic activity over 7-8 weeks in chemically defined media (CDM). The outcomes were achieved by the control of fibroblast growth factor (FGF) signaling and Nodal/Activin/TGFb signaling. We have also defined the cellular developmental pathway from hPSCs to such ectomesenchymal cells using the neural crest markers the low-affinity nerve growth factor receptor (CD271) (Lee et al., 2007; Stemple and Anderson, 1992) , and the platelet-derived growth factor receptor a (PDGFRa) (Morrison-Graham et al., 1992; Weston et al., 2004) , and the MSC markers, CD73 and CD13 (Olivier et al., 2006; Pittenger et al., 1999) .
RESULTS

Signaling Requirement for Early Development of Neural Crest-like Progeny from hPSCs
Generation of osteochondrogenic ectomesenchyme from hPSCs first requires specification of cranial neural crestlike progeny. In order to reproducibly generate strong chondrogenic activity from hPSCs, we first optimized the method for specification of neural crest using CD271 as the readout. Fluorescence-activated cell sorting (FACS) analyses revealed that when H9 hESCs and BJ5 hiPSCs were differentiated in CDM using the conventional embryoid body (EB)-forming culture or 2D differentiation culture in the presence of SB431542 or other Nodal/Activin/TGFb signaling inhibitor (e.g., A83-01 or SJN2511), they generated progeny that expressed CD271 ( Figures 1A and S1 ). The CD271
hi cell population, but not the CD271 lo/À progeny, also expressed PDGFRa at low levels. Both populations lacked CD73 and CD13. The effect of SB431542 was dose dependent at least up to 10 mM ( Figure S1D ). The CD271 hi PDGFRa lo cell development reached a peak around day 6 of differentiation ( Figure S1C ), in parallel with the highest expression of the ''neural crest specifier'' genes PAX3 and PAX7 (Nelms and Labosky, 2010) (Figure 1B) . In contrast, the neuroectoderm marker SOX1 was never induced, and the ESC marker NANOG was downregulated. Furthermore, the isolated CD271 hi (PDGFRa lo ) CD73 À progeny had higher levels of SOX10 and FOXD3
transcripts than the CD271 lo/À (PDGFRa À )CD73 À cells, indicating enrichment of the fraction with neural crestlike progeny ( Figure 1D ). SOX9 is also implicated in the specification of cranial neural crest (Nelms and Labosky, 2010) and is expressed in premigratory human neural crest (Betters et al., 2010) . The SOX9 reporter, GFP (Figures 1F and S1I) and SOX9 transcripts ( Figure S1G ) were expressed in the CD271 hi CD73 À fraction. The PAX3 protein (Figure 1E) and PAX3 transcript ( Figure S1G ) were also detected in the CD271 hi CD73 À fraction.
Furthermore, in sharp contrast to the results obtained from the hPSC differentiation to paraxial mesoderm , when MIXL1 (an early mesendoderm gene)-green fluorescence protein (GFP) knockin hESCs (MIXL1-GFP) (Davis et al., 2008) were differentiated under similar conditions, no MIXL1-GFP + progeny developed ( Figure 1A ). There was also negligible induction of a second mesendoderm transcript, T ( Figure S1B ) . Therefore, neither CD271
À cells were likely to be mesendodermal derivatives. BMP and WNT are implicated in the neural crest specification (Milet and Monsoro-Burq, 2012) . As expected, the BMP inhibitor Noggin suppressed the SB431542-induced development of the CD271 hi PDGFRa lo (CD73 À ) neural crest-like progeny from H9 hESCs ( Figure S1E ). The WNT inhibitor FZD also showed an inhibitory effect, consistent with the findings of Menendez et al. (2011) (Figure S1D ). Interestingly, BMP4 at 10 ng/ml, a concentration sufficient to induce mesoderm (Wang and Nakayama, 2009 ), was as inhibitory as Noggin, and the GSK3 inhibitor that mimics canonical WNT signaling showed weakly inhibitory effects ( Figure S1E ). However, when SOX9-GFP iPSCs were used, the GSK3 inhibitor was found to enhance the genesis of CD271 hi CD73 À cells ( Figure S1I ). Figures S2D and S2E ). As we reported previously , MIXL1-GFP + mesendodermal progeny were never detected during such studies (data not shown). In 3D-pellet culture, the generated mesenchymal cells gave rise to a particle containing an area that weakly stained metachromatically (pink to purple) with Toluidine Blue and immunostained with anti-type II collagen (COL2) antibody at passage 1 (p1) ( Figure S2F ) and p2, but not from p3 to p5. The lack of chondrogenic activity in the primary À progeny in SOX9-GFP hiPSCs differentiated for 6 days.
outgrowth cells (p0), suggests that a short-term expansion of the outgrowth cells is required for its development and/ or accumulation. However, as reported by others (Nakayama and Umeda, 2011), we did not observe robust chondrogenic activity leading to a full-cartilage particle, as found for paraxial mesoderm derived from mPSCs and hPSCs (Nakayama et al., 2003; . Thus, conventional culture methods failed to generate and maintain strong chondrogenic activity from hPSC-derived neural crest-like progeny. to the culture dish in the absence of fibronectin and grew poorly in the medium in which they were specified, i.e., CDM plus SB431542 (SB; Figures 2B and S3A ). Therefore, we tested the effects of growth factors, such as FGF2 that have been used for maintaining neural crest cells (Stemple and Anderson, 1992) and generating chondrogenic activity (Abzhanov et al., 2003) in culture, and of other factors, such as endothelin1, PDGF, and Sonic hedgehog that have been linked to cranial skeletogenesis and ectomesenchymal specification in vivo (Le Douarin and Creuzet, 2009 ). FGF2 alone significantly increased viability and supported growth of the neural crest-like progeny on fibronectin but was often associated with significant slowdown in an early stage of expansion culture. The addition of both FGF2 and SB431542 maintained the growth rate at least until p16 and supported maintenance of the normal karyotype at least to p10 ( Figure S3B ). Direct expansion of the nonmesendodermal progeny mix in CDM in the presence of FGF2 and SB431542 Figure S3D ). The expression of the neural crest genes FOXD3 and SOX10 was quickly downregulated during expansion under either FGF2 or FGF2+SB431542 conditions, even at p1, indicating rapid non-neural commitment of the neural crest-like progeny ( Figure 2E ) (Nelms and Labosky, 2010) . In contrast, the SOX9 transcript was strongly upregulated at p1 and maintained over seven passages under FGF2+SB431542 conditions, whereas the SOX9 transcript was slightly enhanced at p1 and gradually declined after p4 under FGF2 conditions.
Our The ectomesenchymal cells expanded in CDM in the presence of FGF2 or FGF2+SB431542 were subjected to 3D-pellet culture under the PDGF/TGFb/BMP condition. The early (p2) FGF2-expanded cells formed a large cartilage particle that stained metachromatically (pink to purple) with Toluidine Blue, but then lost such chondrogenic activity by p4-p5 ( Figures 4A and 4C ), in keeping with the loss of the CD271 + cell population ( Figures 2C and S3D ).
On the other hand, the (FGF2+SB431542)-expanded cells did not form a particle when subjected directly to pellet culture (no pellet, Figure 4B ), suggesting that (FGF2+ SB431542)-expanded cells are defective in the induction of mesenchymal condensation, a prerequisite for cartilage formation. Supporting this suggestion, 2D-micromass culture demonstrated that inclusion of SB431542 until the point of induction of chondrogenesis using TGFb3 and BMP4 severely inhibited or delayed the formation of cartilage nodules ( Figures S4A and S4B) . Thus, suppression of Nodal/Activin/TGFb signaling allows the CD271 + CD73 + cells to grow but not to initiate chondrogenesis under the action of TGFb and BMP. A brief treatment (''priming'') with TGFb is known to commit mouse neural crest stem cells to mesenchymal lineages (John et al., 2011) . Therefore, we reasoned that stimulation with TGFb before pellet culture might be required for efficient cartilage particle formation. When the (FGF2+SB431542)-expanded cells were passaged once into CDM containing FGF2+TGFb3 (FT), cultured for 3 to 4 days to confluence, and then subjected to 3D-pellet culture, large translucent full-cartilage particles filled with hi cells. Pink, SOX9; blue (nucleus), DAPI; graph, the value of % SOX9 + nuclei was the average of scoring from four areas (n = 4 technical repeats, mean ± SD); ++, strong signal; +, weaker signal; isotype control, Figure S4J . (E) SOX9-GFP expression in the FSB-expanded CD271 hi cells. SOX9-GFP hiPSCs were differentiated, and the CD271 hi CD73 À progeny were isolated and expanded under FSB for five passages as in (A) and then FACS analyzed ( Figure S3H ). H9 hESC-derived, FSB-expanded cells in (B) were used as the GFP-negative control. (F) Chondrogenic activity of the CD271 hi or CD271 lo progeny maintained under FSB. Cells were grown under FSB and F conditions for five passages and subjected to 2D-micromass cultures, followed by Alcian Blue staining and quantification. *p < 0.05 (n = 3 independent cultures, two masses/culture, mean ± SD).
matrices that stained metachromatically with Toluidine Blue and immunostained with the COL2 antibody were generated effectively (Figures 4Bi, 4Bv, 4Bvi, S4F, and S4H) . The SB431542-dependent maintenance of chondrogenic activity during expansion culture was confirmed by the quantitative comparison of sulfated glycosaminoglycan (sGAG) levels in 24 days of pellet culture using ectomesenchymal cells maintained under FGF2+ SB431542 (FSBp11/FT) and under FGF2 alone (Fp4) ( Figure 4C ). When FGF2+TGFb3 pretreatment was extended for a few more passages (FTp2), the cells maintained their particleforming capability but gradually lost their chondrogenic potential, resulting in particles with a small cartilaginous area ( Figure 4Bii ). Pretreatment with D10 medium also induced pellet-forming activity in the (FGF2+SB431542)-expanded cells, which led to a full-cartilage particle (Figure (E) Effect of FT treatment on SOX9 protein expression. FSB-expanded p7 ectomesenchymal cells followed by FT culture (i.e., p8) were treated and analyzed as in Figure 3D . Graph, n = 4 technical repeats, mean ± SD. Isotype control, Figure S4J . (F) Real-time RT-PCR analysis for investigating the effect of FT treatment on SOX9 gene expression (n = 3 technical repeats, mean ± SD).
in FGF2-expanded cells (Figures 4Aiii and 4Aiv). A brief
TGFb pretreatment thus seemed to enhance the condensing capacity but not the chondrocyte-forming ability of the expanded ectomesenchymal cells. In support of this observation, the proportion of cells expressing SOX9 protein increased only slightly from 76%-83% (Figure 3D) to 97% ( Figure 4E ), and the transcription levels of SOX9 ( Figure 4F ), SOX5, and SOX6 (data not shown) were unaltered by the 4-day FGF2+TGFb3 treatment. In contrast, FGF2+TGFb3 treatment (/FT, Figure 4D ) led to dramatic downregulation of the expression of CD271 in 3 to 4 days and complete loss of expression during the subsequent culture for two passages (/FTp2). A similar change was observed with D10 treatment. Since the short-term (FGF2+TGFb3)-treated cells effectively formed cartilage particles (Figures 4Bi, 4Biii , and 4Bv), the reduction/loss of CD271 expression may be an early indicator that chondrogenic activity will be lost later.
TGFb upregulates the production of extracellular matrix proteins and cell surface molecules such as fibronectin, N-cadherin, and N-CAM (CD56), which are involved in the initiation of precartilaginous mesenchymal condensation (Chimal-Monroy and Díaz de Leó n, 1999). CD56 but not N-cadherin was expressed on most of the (FGF2+SB431542)-expanded ectomesenchymal cells (Figures 4D and S3E) . However, treatment with FGF2+TGFb3 or D10 resulted in the upregulation of N-cadherin. In addition, the (FGF2+SB431542)-expanded cells exposed to FGF2+TGFb3 for two passages and the FGF2-expanded cells (Fp2) (B) Maintenance of sGAG production capacity. The ectomesenchymal cells maintained under FSB for 11-16 passages followed by FT treatment, and the freshly isolated chondrogenic paraxial mesoderm (PM) were subjected to pellet culture. The capacity for sGAG production is displayed as in Figure 4C . Negative control, hESCs; positive control, bovine articular cartilage (n = 3 technical repeats, mean ± SD).
(C) ''Full-cartilage''-forming capacity remained in the FSB-expanded p13 ectomesenchymal cells derived from CD271 hi CD73 À H9 progeny. Toluidine Blue staining.
(D) SB431542-dependent maintenance of chondrogenic activity. The p10 ectomesenchymal cells were passaged to either FSB for four passages (FSBp14) or F for two passages (/Fp2) and then subjected to FT treatment and 3D-pellet culture. The capacity for sGAG production is displayed as in (B). *p < 0.05 (n R 3 independent cultures, one pellet/culture, mean ± SD). (E) Real-time RT-PCR analysis for investigating the effect of FSB on maintaining SOX9 expression (n = 3 technical repeats, mean ± SD).
Furthermore, when 3D-pellet culture was performed, the (FGF2+SB431542)-expanded ectomesenchymal cells maintained their chondrogenic activity during further expansion (p11-16), as judged by the accumulation of sGAGs in the developed cartilage particles ( Figure 5B) , and the ''full cartilage''-forming activity was preserved at least to p13 ( Figure 5C ). Interestingly, such chondrogenic activity was indistinguishable from that of the KDR À PDGFRa + chondrogenic paraxial mesodermal cells (PM) we previously reported Figure 6 ). In some cases, the culture condition was shifted to the FGF2 condition from p4 (FSB/F). As a control, the CD271 First, gene ontology (GO) analysis suggested that (FGF2+SB431542)-expanded cells would likely be involved in ''DNA replication,'' ''mitotic cell cycle,'' and ''cell division'' ( Figure 6D ), while (FGF2+SB431542/FGF2)-cultured cells seemed to have the property of differentiated cells and would likely be involved in ''cell adhesion,'' ''angiogenesis,'' and/or ''skeletal system development.'' Furthermore, as for the predicted developmental potentials, (FGF2+SB431542)-expanded cells still showed relevance to ''peripheral nervous system development,'' ''melanocyte differentiation,'' and/or ''eye development'' ( Figure 6D ), although essential genes such as SOX10, ASCL1-4, NEUROD1/2/4/6, NEUROG1-3, OLIG1-3, MITF, and PAX6 (Nelms and Labosky, 2010) were either not (yet) expressed or expressed at very low levels (FPKM %1; data not shown). In contrast, (FGF2+SB431542/FGF2)-cultured cells seemed to be associated more with ''ossification,'' ''odontogenesis,'' and ''embryonic vicerocranium morphogenesis.'' In addition, consistent with the removal of SB431542, enhancement of ''TGFb receptor signaling'' was suggested.
Comparison of genes in either cell population that showed more than a 2.5-fold difference in expression level ( Figure 6C ; Tables S3 and S4 ) supported the GO analysis in that genes preferentially expressed under FGF2+SB431542 conditions represented many, if not all, aspects of neural crest (stem) cells and primitive ectomesenchyme. Such genes included LIN28A/B, TRIM71(LIN41) and MYCN (Ecsedi and Grosshans, 2013; Rehfeld et al., 2015) , TWIST1/ 2, ALX1/3/4, SOX8/9 (Nelms and Labosky, 2010), and NES as well as stem cell factor receptor (KIT). In contrast, TGFB3 and other TGFb-induced genes such as DCN and THBS1/2 were induced when SB431542 was removed (FSB/F). Interestingly, the FGF2+SB431542 condition supported the expression of COL2A1, the type II collagen gene, SOX9 regulator genes such as MAF (Huang et al., 2002) and ZBTB16 (Liu et al., 2011), and LBH (Powder et al., 2014) , while the FGF2+SB431542/FGF2 condition induced COL1A1/1A2 and RUNX1/2 expression, supporting their predicted ''ossification'' function. Consistent with FACS analyses, expression of NGFR (CD271), the cell surface marker gene for neural crest, was found to be supported under FGF2+SB431542 conditions, and ANPEP (CD13) was induced under FGF2+SB431542/FGF2. On the other hand, among genes commonly expressed in cells cultured under both conditions, the presence of SOX4 and SOX12 supports the likelihood that both are embryonic neural/mesenchymal progenitor cells (Bhattaram et al., 2010 Figure 7E ) and COL10A1 transcript (3D-pellet culture, Figure 7F ) during chondrogenesis suggested that the ectomesenchymal cellderived chondrocytes matured into hypertrophic chondrocytes. Such a property of the ectomesenchymal cells might reflect a more general property of hPSC-derived chondrogenic cells. Therefore, we also examined the cartilage particles produced by the hPSC-derived KDR À PDGFRa + chondrogenic paraxial mesodermal progeny . First, we significantly improved the yield of KDR À PDGFRa + progeny expressing higher levels of MEOX1, TCF15, as well as UNCX ( Figure S5 ) by replacing BIO with CHIR99021 and inhibiting FGF signaling with PD173074 at a later stage of differentiation. Next, cartilage particles were generated and transplanted subcutaneously. The transplanted particles were mineralized at the periphery, but four of six particles stably maintained internal unmineralized cartilaginous areas even after 12 weeks ( Figure 7A ). In some case, the whole cartilaginous particles remained unmineralized ( Figure 7B ). These results indicate that the strong tendency of terminal Tables S3 and S4 except for few with * that gave slightly more variations (0.05 < p < 0.1). ND, not determined.
(D) GO analysis. Selected GO categories from Table S1 (upper) and a selected list of development-related GO terms from Table S2 (lower).
(E) RT-PCR confirmation of the relative gene expression levels predicted by the FPKM values (n = 3 independent cultures, mean ± SD).
maturation in vivo is not a general property of the hPSC-derived chondrogenic progeny. The neural crestderived ectomesenchymal cells may innately possess such a property or may have been primed for it during expansion. Endochondral ossification would replace the transplanted cartilage (consisting of human chondrocytes) with bone tissue made by osteoblasts and osteocytes of murine origin. We therefore addressed the question of whether the donor human chondrocytes completely disappeared from the bony particles generated in 12 weeks. As expected, immunohistochemical analyses revealed that the large hypertrophic chondrocytes showed human-specific signals ( Figure 7G ). Interestingly, human cells were also detected in a marrow-like space and around the COL1-positive bone pieces ( Figure 7H ), suggesting that the transplanted cartilage particles may contain cells with osteoblastic/ osteocytic potential. À neural crest-like progeny in comparison with those developed with the freshly isolated KDR À PDGFRa + paraxial mesoderm, derived from H9 hESCs under the CHIR99021-based 4i+P conditions (A) and from HES3 hESCs under the BIO-based 2i condition (B) . Cartilage particles were transplanted into NSG mice (A, C, and D) and NODScid mice (B) subcutaneously for 12 weeks, recovered, fixed, sectioned, and stained with Toluidine Blue (cartilaginous area is in purple) and von Kossa (bony area is in black). (E and F) Cartilage gene expression during chondrogenesis cultures. The FSB-expanded p7 cells were subjected to 2D-micromass culture (E) or 3D-pellet culture (F) and then real-time RT-PCR (n = 3 technical repeats, mean ± SD). (G and H) Immunostaining with anti-human mitochondria (hMit) antibody. Sections of a bony particle made in (C) and (D) were stained with H&E (G) or stained with hMit antibody (pink, G and H) and anti-type I collagen (COL1) antibody (green, H), followed by counterstaining with DAPI (blue). Negative controls, Figures S4K and S4L . from hPSCs in CDM was achieved more quickly than previously reported, and the resultant ectomesenchymal cells displayed long-term chondrogenic activity.
Quantitative data on the efficiency of genesis of SOX9-expressing chondroprogenitors from hESCs were first shown by Oldershaw et al. (2010) Figure S3A ). Approximately 76%-85% of these cells continued to express SOX9 protein on days 27-33 (p8-p10), a proportion that increased slightly to about 97% after 3 days of treatment with FGF2+TGFb3.
Further expansion yielded approximately 1 3 10 7 chondrogenic ectomesenchymal cells per hPSC by day 51 (p16, 24 population doublings). Thus, the method described here allows human chondrogenic cells to expand for an extended period without the loss of purity and chondrogenic activity, resulting in a much larger yield of chondroprogenitor cells (although not homogenous) from hPSCs than previously attained. The effect of SB431542 on expansion of endothelial progenitors derived from mouse and human ESCs has also been reported (James et al., 2010; Watabe et al., 2003) . A lack of Nodal/Activin/TGFb signaling may generally promote proliferation and prevent terminal differentiation of embryonic stem/progenitor cells. In this respect, the ways in which FGF2+SB431542 helps to maintain SOX9 and CD271 while suppressing N-cadherin expression during expansion of the chondrogenic CD271 ) may therefore represent proliferating cranial neural crest, with a slight commitment to non-neural lineages.
Genesis of MSC-like cells from hESCs directly or via neuroectoderm specification has been demonstrated (Chambers et al., 2009; Mahmood et al., 2010) . As shown in Figure S4D , the colonogenic (CFU-F) activity, representing self-renewal activity of MSCs, emerged as early as p2 of the expansion culture under FGF2 alone (i.e., in CD271 À CD73 cells) or FGF2+SB431542 (i.e., in CD271 + CD73 + cells). However, we were unable to demonstrate significant adipogenic or osteogenic activity in either cell type (data not shown), although the GO analysis predicted osteogenic activity in cells generated under FGF2 (data not shown) and FGF2+SB431542/FGF2 conditions. This discrepancy may be due to some degree of heterogeneity in the cell types generated under these conditions or to the assay method employed, which is widely used for MSCs (Pittenger et al., 1999) , but is less well validated for mesenchymal cells derived from human neural crest. Furthermore, the FGF2+SB431542 conditions applied to the expansion culture of mouse bone marrow MSCs resulted in inhibition of proliferation and promotion of adipocytic differentiation (data not shown). The CD271 + CD73 + ectomesenchymal cells are therefore very likely not to be MSCs, although the possibility that they are derived from an MSC-like precursor has not been excluded. Thus, hPSC-derived chondrogenic ectomesenchymal cells are amenable to large-scale production in CDM without loss of activity. Although some hESC-derived neural crest stem cells are known to self-renew in culture for an extended period, during which they maintain the capacity to produce multipotential MSC-like activity (Menendez et al., 2011) , no previous reports have described a method as simple and effective as ours for generating large quantities of (osteo)chondrogenically committed mesenchymal cells under clinically applicable, defined conditions. Therefore, the chondrogenic ectomesenchymal cells produced by the culture technology described are set to become a competitive alternative to adult MSCs, especially for craniofacial regenerative therapy. Moreover, taking advantage of high yields of chondroprogenitor cells, we have successfully modeled neonatal-onset multisystem inflammatory disease by applying our method to patient-derived iPSCs (Yokoyama et al., 2015) . 
EXPERIMENTAL PROCEDURES
Neural Crest Cell Differentiation from hPSCs
For generating neural crest-like progeny, H9 hESCs and BJ5 hiPSCs were transferred to gelatin-coated dishes and cultured feeder free in the differentiation medium: CDM supplemented with SB431542. The SOX9-GFP hiPSCs were directly induced to differentiate by changing the medium to differentiation medium.
Paraxial Mesoderm Generation from hESCs
The hPSCs were differentiated as described (''2i'' condition) or using improvements involving CHIR99021, Noggin, PD173074, and PDGF with or without SB431542 (''3i+P'' or ''4i+P,'' Figure S5 ).
Flow Cytometry
FACS analysis and cell sorting were performed as described . Intracellular staining for FACS analysis using mouse anti-PAX3 monoclonal antibody was performed according to the manufacturer's recommendations.
Ectomesenchymal Cell Genesis and Expansion
The differentiated hPSCs before and after sorting for CD271 hi CD73
À were plated onto fibronectin-coated dishes and cultured in CDM supplemented with FGF2 and/or SB431542 (or other small molecules) or in the serum-containing D10 medium.
Immunofluorescence Detection of SOX9
The CD271 hi CD73 À neural crest-like progeny were cultured in an eight-well chamber slide for 3 days in CDM containing either FGF2+SB431542 or FGF2+TGFb3 and immunostained with the anti-hSOX9 polyclonal antibody.
Chondrogenesis Assays
2D-micromass culture and 3D-pellet culture were performed and analyzed as described (Nakayama et al., 2003; Tanaka et al., 2009; .
Quantification of Sulfated Glycosaminoglycans
DNAs and sulfated glycosaminoglycans (sGAGs) from micromasses and cartilage particles were isolated, quantified, and analyzed as described .
Subcutaneous Transplantation and Immunohistological Analysis
Cartilaginous particles were transplanted under the dorsal skin of NODScid or NODScid Il2rg À/À (NSG) mice for 8-12 weeks and analyzed as described . To detect remaining human cells, the fixed particles were first decalcified and then paraffin embedded, sectioned, and stained with the mouse antihuman mitochondria monoclonal antibody.
Gene-Expression Profiling
Total RNAs were isolated and reverse transcribed (RT), and realtime PCR was performed using the Taqman Gene Expression Assay.
The results were displayed as described . RNA sequencing was performed on an Illumina HiSeq 1500. Sequenced reads were deposited to Gene Expression Omnibus (GSE64752) and mapped against the human reference genome (GRCh37). Expression levels were calculated as fragments per kilobase of exon per million mapped fragments (FPKMs) ( Tables S1, S2 , S3, and S4). Yokoyama, K., Ikeya, M., Umeda, K., Oda, H., Nodomi, S., Nasu, A., Matsumoto, Y., Izawa, K., Horigome, K., Kusaka, T., et al. (2015) . Enhanced chondrogenesis of induced pluripotent stem cells from patients with neonatal-onset multisystem inflammatory disease occurs via the caspase 1-independent cAMP/protein kinase A/ CREB pathway. Arthritis Rheumatol. 67, 302-314.
SUPPLEMENTAL INFORMATION
Zhao, J., Li, S., Trilok, S., Tanaka, M., Jokubaitis-Jameson, V., Wang, B., Niwa, H., and Nakayama, N. µM CHIR99021 from day 0 to day4, and were analyzed by FACS on day 6 (f). Note that the SOX9-GFP hiPSC differentiation was not very efficient under the standard CDM+SB condition (Fig. 1f) . It has been demonstrated that activation of canonical WNT signaling and suppression of BMP signaling leads to neural crest formation from hPSCs (Menendez et al., 2011) . Although BMP inhibition was not included, CHIR99021 treatment for the initial 4 days of differentiation was found to enhance the CD271 + GFP +/-cell genesis by day 6. repeats, mean ± SD) Note: except for COL10A1 expression, which was first detected after day 14, the expression of other genes was upregulated between days 6 and 10 and the level increased by day 14. In contrast to human paraxial mesoderm (Fig. S3e) , 2) the CD271 + CD56 + TNAP (tissue-nonspecific alkaline phosphate) + uncultured hMSCs are highly enriched in chondrogenic activity that is difficult to maintain during conventional culture, as is the expression of CD271, CD56 and TNAP (Aicher et al., 2011) , and 3) one of the developmental origins of bone marrow MSCs is neural crest (Morikawa et al., 2009; Takashima et al., 2007) .
Therefore, ectomesenchymal cells were plated at clonal densities at each passage, and the (a, b) Requirement for Noggin and determination of proper timing. H9 hESCs were differentiated for 7 days toward paraxial mesoderm as described in "Supplemental Experimental Procedures".
Briefly, differentiation was initiated under modified 3i (a) and 3i+ P (b) conditions, in which Noggin (N) was added on days 0, 1 or 2 (Nd0-Nd2) (a, b), and removed from day 3 (Nd3-) (b). vitronectin-coated plate in E8 medium (Invitrogen). Antibodies, cytokines, media and supplements, buffers and specialized tissue culture plates were generally sourced as described (Wang and Nakayama, 2009; Wang et al., 2010) .
Embryoid body (EB)-outgrowth culture
Mesenchymal cells were generated from hESCs as described (Hwang et al., 2006) mM GlutaMax, or in SR medium. The medium was changed every 3-4 days, and the cells were passaged on reaching 80-90% confluence.
Neural crest cell differentiation from hPSCs.
H9 hESCs and BJ5 hiPSCs were treated with collagenase I to generate clumps, which were plated onto gelatin-coated dishes without feeder cells. The clumps were cultured for 6 days in Differentiation medium: CDM supplemented with 10 µM SB431542 (Tocris, Ellisville MO) and/or other protein factors and small molecules at 37 o C under 5% CO 2 /5% O 2 . Media was changed once on day 3. The SOX9-GFP hiPSCs maintained feeder-free in the E8 medium were directly induced to differentiate by changing the medium to Differentiation medium and culturing for 6 days. When specified, CHIR99021 (BioVision, Milpitas CA) was added from day 0 to day 4.
Factors used: mNoggin-Fc chimera (Noggin, R&D) at 100 ng/ml, mFrizzled8-Fc chimera (FZD, R&D) at 2 µg/ml, hBMP4 (R&D) at 10 ng/ml, BIO (Calbiochem, San Diego CA) or CHIR99021 at 2 µM, SB431542 at 1-10 µM, A83-01 (Tocris) at 0.1 µM, SJN2511 (Tocris) at 1 µM, and LDN193189 (Stemgent, Cambridge MA) at 0.5 µM. On the day of harvest, a suspension of single cells was prepared by treatment of the culture with 0.05% (w/v) trypsin-EDTA or TrypLE Select (diluted 2.5 fold with 0.5 mM EDTA in PBS) (Invitrogen).
Paraxial mesoderm generation from hPSCs
The HES3 and H9 hESCs were differentiated using the original method based on BIO and
Noggin as described (here designated '2i condition') . Briefly, hESCs were derived progeny (Figs. 1f and S1h) were determined by the corresponding cell population derived from H9 hESCs (data not shown). FACS analysis was performed on LSRII (BD); cell sorting was done with Aria (BD). Viable single cells were gated using 4',6-diamidino-2-phenyindole (DAPI, Sigma). Sorted cells ranged in purity from 92 to 96%.
Ectomesenchymal cell genesis and expansion
The single-cell suspension from differentiated hPSCs before or after sorting with antibodies to CD271 and CD73 were plated onto fibronectin-coated dishes (10 µg/ml human fibronectin
[Sigma], overnight at 4 o C) and cultured in CDM supplemented with various factors or small molecules, or in D10 medium at 37 o C under 5% CO 2 /5% O 2 . Factors used: FGF2 at 5-10 ng/ml, hPDGF-BB at 10 ng/ml, SB431542 at 1-10 µM, A83-01 at 0.1 µM, SJN2511 at 1 µM, and LDN193189 at 0.5 µM. Generated cells were passaged every 3-4 days by 0.05% Trypsin-EDTA or diluted TrypLE Select. For 3D-pellet culture, cells were passaged into CDM containing 5 ng/ml FGF2 + 10 ng/ml TGFβ3 (R&D) or D10 medium, and maintained for 3-4 days (without further passage) or for 9-11 days (with 2 passages) at 37 o C under 5% CO 2 , prior to forming a pellet.
Growth curves and karyotype analysis
Mesenchymal cells were maintained by passaging every 3 days in CDM containing 5-10 ng/ml FGF2 and 3-10 µM SB431542. The total number of cells in each passage was calculated as a ratio of harvested cell number to seeded cell number, multiplied by the calculated cell number of the previous passage. The p10 cells were karyotyped with a standard G-banding technique.
Immunofluorescence detection of SOX9
The CD271 Grove, PA), and finally with AlexaFluor (AF) 594-conjugated streptavidin (S32356, Invitrogen).
The stained slides were inspected with a BX61 fluorescence microscope (Olympus, Center
Valley, PA) one day after being mounted with a DAPI-containing solution (Invitrogen).
Chondrogenesis assays
TGFβ signaling is essential for normal chondrogenesis from cranial neural crest (Chai et al., 2003; Cheah et al., 2010) , FGF and TGFβ signaling are implicated in mesenchymal condensation during limb, vertebral and craniofacial skeletogenesis (Kronenberg et al., 2009 ).
Therefore, 2D-micromass culture was performed with expanded ectomesenchymal cells (1.5 x10 5 cells) spotted in 5 µl onto a fibronectin-coated 24-well plate (BD), in serum-free chondrogenic medium supplemented with 40 ng/ml PDGF-BB and 1% (v/v) FBS (Nakayama et al., 2003; Tanaka et al., 2009; . On day 6, 10 ng/ml TGFβ3 either supplemented or replaced PDGF, and on day 10, 50 ng/ml BMP4 was added (PDGF/TGFβ/BMP, or PTB) . In some experiments, FGF2 or FGF2+SB431542 was added instead of PDGF on day 0, followed by replacement with TGFβ3 on day 6 and addition of BMP4 on day 10 (FGF/TGFβ/BMP or FGF+SB/TGFβ/BMP, respectively). The 2D cultures were maintained at 37 o C under 5% CO 2 /5% O 2 for 14-16 days, and either fixed with Z-Fix, and stained with 1% (w/v) acid Alcian Blue (Sigma) pH 1, as described (Nakayama et al., 2003; Tanaka et al., 2009; , or subjected to analyses of DNA, RNA and sulfated glycosaminoglycans (sGAGs). The stained micromasses were then treated with 400 µl/well of 4 M guanidine hydrochloride (Sigma) in Tris·HCl-EDTA pH 7.5 (Hoemann, 2004) . The absorbance of the extract was measured at 600 nm (OD600) using SpectraMax M2 (Molecular Devices, Sunnyvale CA) to determine the relative amount of bound
The isolated total RNAs were reverse transcribed (RT), and real-time polymerase chain reaction (PCR) was performed using the Taqman Gene Expression Assay and ABI7900 (Applied Biosystems, Foster City CA) as described Zhao et al., 2014) . The expression levels of individual genes from triplicate reactions (n=3) were normalized against EEF1A1 transcript. The mean relative expression is presented in a bar or line graph with SD shown as a thin vertical line.
For RNA Sequencing analysis (RNA-seq), three independent sets of (FGF2+SB431542)- Sequenced reads were mapped against the human reference genome (GRCh37), using TopHat v2.0.12 (http://ccb.jhu.edu/software/tophat/index.shtml). Expression levels were calculated as fragments per kilobase of exon per million mapped fragments (FPKMs) using Cufflinks v2.1.1 (http://cole-trapnell-lab.github.io/cufflinks). Principal component analysis of protein coding genes was performed using R (version 3.0.1). Gene ontology analysis was performed using an inhouse program. The raw data have been deposited to GEO (#GSE64752), and analyzed data are summarized in Tables S1-4 .
Statistical Analysis
The P-value was determined by the Student-t test using Excel (Microsoft, Redmond WA) or KaleidaGraph (Synergy, Reading PA) software. P values <0.05 were considered significant.
